|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0087111,
umls-concept:C0144576,
umls-concept:C0205179,
umls-concept:C0205210,
umls-concept:C0278502,
umls-concept:C0332174,
umls-concept:C0332293,
umls-concept:C1172402,
umls-concept:C2828372
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2006-9-13
|
|
pubmed:abstractText |
The clinical efficacy and safety of weekly paclitaxel therapy were studied retrospectively in 17 patients with advanced and recurrent gastric cancer who had previously been treated with TS-1 therapy. The overall response rate was 0%, but MST was 495 days. The adverse effects observed were grade 3 leukopenia in 2 patients (11.8%) and grade 1 and 2 alopecia in 13 patients (76.5%). However, weekly paclitaxel therapy was performed for all outpatients. Weekly paclitaxel therapy could be useful and safe as second-line chemotherapy.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1257-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16969021-Aged,
pubmed-meshheading:16969021-Alopecia,
pubmed-meshheading:16969021-Antimetabolites, Antineoplastic,
pubmed-meshheading:16969021-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:16969021-Drug Administration Schedule,
pubmed-meshheading:16969021-Drug Combinations,
pubmed-meshheading:16969021-Female,
pubmed-meshheading:16969021-Humans,
pubmed-meshheading:16969021-Leukopenia,
pubmed-meshheading:16969021-Male,
pubmed-meshheading:16969021-Middle Aged,
pubmed-meshheading:16969021-Neoplasm Recurrence, Local,
pubmed-meshheading:16969021-Oxonic Acid,
pubmed-meshheading:16969021-Paclitaxel,
pubmed-meshheading:16969021-Quality of Life,
pubmed-meshheading:16969021-Stomach Neoplasms,
pubmed-meshheading:16969021-Survival Rate,
pubmed-meshheading:16969021-Tegafur
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
[Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
|
|
pubmed:affiliation |
Gastroenterological Center, Medical Center, Yokohama City University.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
